NCT07473687 Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room
| NCT ID | NCT07473687 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Veterans General Hospital, Taiwan |
| Condition | Cholecystitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 315 participants |
| Start Date | 2026-01-08 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 315 participants in total. It began in 2026-01-08 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the feasibility and accuracy of a non-contact, camera-based physiological monitoring technology in a perioperative setting (including anesthesia induction, surgery, and recovery).Conventional vital sign monitoring tools-such as ECG leads, blood pressure cuffs, and pulse oximeters-require direct skin contact, which may pose risks of cross-infection or skin injury in vulnerable populations (e.g., newborns or elderly patients). This research utilizes remote Photoplethysmography (rPPG) technology to estimate vital signs, including heart rate, blood pressure, and blood oxygen saturation (SpO2), by analyzing facial video captured via standard camera devices (Logitech C930, iPhone 16 Pro Max, and Samsung Galaxy S24 Ultra).The primary goal is to assess the consistency and stability of this non-contact system compared to clinical gold-standard monitors (Masimo Root, SedLine O3, and Radical-7) during actual surgical procedures. The findings will serve as a foundation for developing non-invasive, supplementary monitoring tools in dynamic clinical environments.
Eligibility Criteria
Inclusion Criteria: 1. Patients aged \>18 years. 2. Patients scheduled to undergo surgical procedures under general anesthesia. 3. American Society of Anesthesiologists (ASA) Physical Status I, II, or III. Exclusion Criteria: 1. Patients aged \< 18 years. 2. Pregnant patients. 3. Patients whose facial images cannot be captured or recognized (e.g., due to surgical drapes, severe edema, or major trauma). 4. Patients who refuse to participate or have not signed the informed consent form. 5. Other cases deemed unsuitable for the study by the clinical physician or anesthesiologist.
Contact & Investigator
Hui-Hsuan Ke
PRINCIPAL INVESTIGATOR
Taipei Veterans General Hospital, Taiwan
Frequently Asked Questions
Who can join the NCT07473687 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cholecystitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07473687 currently recruiting?
Yes, NCT07473687 is actively recruiting participants. Contact the research team at kehuihsuan0221@gmail.com for enrollment information.
Where is the NCT07473687 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07473687 clinical trial?
NCT07473687 is sponsored by Taipei Veterans General Hospital, Taiwan. The principal investigator is Hui-Hsuan Ke at Taipei Veterans General Hospital, Taiwan. The trial plans to enroll 315 participants.